Hunan Hansen Pharmaceutical Co. Ltd. (002412.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

17.0x

Market Cap

CNY 5.64B

MomentumView details →

1D Return

+10.01%

YTD Return

+51.01%

RSI (14)

51.0

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

17.0x

Market Cap

CNY 5.64B

RSI (14)

51.0

MomentumView details →

1D Return

+10.01%

YTD Return

+51.01%

ProfitabilityView details →

Gross Margin

78.06%

Net Margin

21.81%

EBITDA Margin

27.18%

ROE (TTM)

9.30%

ROA (TTM)

8.24%

Asset Turnover

0.38x

GrowthView details →

Revenue YoY

+1.27%

EPS YoY

+30.02%

FCF YoY

+20.01%

Revenue CAGR 3Y

+4.28%

EPS CAGR 3Y

+5.73%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.02x

Current Ratio

4.80x

Quick Ratio

4.05x

Div Yield

3.10%

Div Rate

CNY 0.30

Div Growth 1Y

+0.00%

Financials snapshotView financials →

Revenue (TTM)

1.03B

Net Income (TTM)

225.27M

Op. CF (TTM)

185.55M

Latest newsMore news →

Hansen Pharmaceutical completed the change registration of its Drug Manufacturing License, obtaining a new license from the Hunan Provincial Drug Administration, valid until November 6, 2030.10d ago

On August 25, 2026, the Shenwan primary industry pharmaceutical and biological sector rose 1.22% to 7852.96 points at midday, with multiple stocks hitting the daily limit, including Transgen Life, Jiheng Pharmaceutical, Weiguang Biological, Huasen Pharmaceutical, Hansen Pharmaceutical, and Hainan Haiyao.12d ago

Similar companies

广东鸿图002101.SZ 红棉股份000523.SZ 铭普光磁002902.SZ 精锻科技300258.SZ 精华制药002349.SZ 北陆药业300016.SZ Find similar companies →

Latest newsMore news →

Hansen Pharmaceutical completed the change registration of its Drug Manufacturing License, obtaining a new license from the Hunan Provincial Drug Administration, valid until November 6, 2030.10d ago On August 25, 2026, the Shenwan primary industry pharmaceutical and biological sector rose 1.22% to 7852.96 points at midday, with multiple stocks hitting the daily limit, including Transgen Life, Jiheng Pharmaceutical, Weiguang Biological, Huasen Pharmaceutical, Hansen Pharmaceutical, and Hainan Haiyao.12d ago